We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Tata Motors leads Nifty 100 companies in R&D spending, focusing on mobility solutions and alternative fuel technologies.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...

Sartorius invests in new production line in Bengaluru to meet global demands, doubling capacity for chromatography systems.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

India aims for Rs 17,000 crore investment in pharma R&D by FY28 through PRIP scheme, focusing on innovation and growth.

Finnish drugmaker Orion Corporation has announced that it is establishing a new research and development (R&D) center in Cambridge, UK, during 2025 to accelerate its global growth strategy and the ...

The Department of Pharmaceuticals has invited expressions of interest for project funding under the PRIP scheme, aiming to transform India into a global R&D hub in the Pharma MedTech sector.

Our Bureau, New Delhi Monday, March 10, 2025, 17:10 Hrs [IST] The Department of Pharmaceuticals (DoP) has released the Expre ...